Skip to main content
. 2023 Feb 13;23:52. doi: 10.1186/s12871-023-02012-4

Table 4.

Insulin resistance indicators in the two groups

Group C (n = 50) Group E (n = 50) P-value
FG(mmol/L, mean ± SD)
 Pre 1d 5.2 ± 0.9 5.2 ± 0.7 0.666
 Pos 1d 7.4 ± 1.2* 6.7 ± 1.2* 0.010
FINS(mU/L, mean ± SD)
 Pre 1d 7.6 ± 1.4 7.5 ± 1.7 0.706
 Pos 1d 10.8 ± 1.9* 9.6 ± 2.2* 0.005
Homa-IR (mean ± SD)
 Pre 1d 1.8 ± 0.6a 1.8 ± 0.6a 0.609
 Pos 1d 3.6 ± 1.2* 3.0 ± 1.2* 0.007
Homa-IS (M(P25, P75))
 Pre 1d 0.5(0.4,0.8)a 0.6(0.5,0.8)a 0.605
 Pos 1d 0.3(0.2,0.4)* 0.4(0.3,0.5)* 0.018
Homa-β (M(P25, P75))
 Pre 1d 81.0(67.2,173.2)a 89.5(75.9,117.3)a 0.504
 Pos 1d 58.4(50.0,61.1)* 60.9(53.4,66.8)* 0.045

FG Fasting glucose, FIns Fasting insulin, HOMA-IR Homeostasis model assessment-insulin resistance index, HOMA-IS Homeostasis model assessment-insulin sensitivity index, HOMA-β Homeostasis model assessment-β; Pre 1d Preoperative day 1, Pos 1d Postoperative day 1, SD Standard deviation, M Median, P Percentile

P-value indicates the statistical difference between the two groups at the same time point

*Indicates a statistically significant difference compared with Pre 1d, P < 0.05

aIndicates values that were not subject to normal distribution (ManneWhitney U test)